Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases-Reference-Cited by-同舟云学术

Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases

Published:2008-05 Issue:9 Volume:18 Page:2793-2798
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Claridge Stephen,Raeppel Franck,Granger Marie-Claude,Bernstein Naomy,Saavedra Oscar,Zhan Lijie,Llewellyn David,Wahhab Amal,Deziel Robert,Rahil Jubrail,Beaulieu Normand,Nguyen Hannah,Dupont Isabelle,Barsalou Annie,Beaulieu Carole,Chute Ian,Gravel Serge,Robert Marie-France,Lefebvre Sylvain,Dubay Marja,Pascal Roussen,Gillespie Jeff,Jin Zhiyun,Wang James,Besterman Jeffrey M.,MacLeod A. Robert,Vaisburg Arkadii

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference33 articles.

1. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

2. Protein kinases — the major drug targets of the twenty-first century?

3. Vascular Endothelial Growth Factor (VEGF) Inhibition - A Critical Review

4. Review of Clinic Trials: Agents Targeting c-Met

5. Met, metastasis, motility and more

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, Characterization, DFT Calculations and Anticoagulant Activity of Symmetrical and Unsymmetrical N-Aryl Thiourea Derivatives;J CHEM SOC PAKISTAN;2024

2. Discovery of New Quinazoline Derivatives as VEGFR-2 Inhibitors: Design, Synthesis, and Anti-proliferative Studies;Anti-Cancer Agents in Medicinal Chemistry;2023-11

3. Novel 3-phenylquinazolin-2,4(1H,3H)-diones as dual VEGFR-2/c-Met-TK inhibitors: design, synthesis, and biological evaluation;Scientific Reports;2023-10-30

4. Design, synthesis, and biological evaluation of thiazole/thiadiazole carboxamide scaffold-based derivatives as potential c-Met kinase inhibitors for cancer treatment;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-08-29

5. Identification of potentially high drug-like VEGFR2/c-Met dual-target type II kinase inhibitors with symmetric skeletons based on structural screening;Journal of Biomolecular Structure and Dynamics;2023-04-12